{
  "symbol": "MO",
  "year": 2023,
  "period": "Q3",
  "competition_summary": [
    {
      "competitor": "FTC",
      "mentions": 14,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "U.S. Court of Appeals",
      "mentions": 1,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "District Court",
      "mentions": 4,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "the U.S. District Court",
      "mentions": 4,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "State",
      "mentions": 1,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "the U.S.",
      "mentions": 1,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "Board of Directors",
      "mentions": 2,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "PM USA",
      "mentions": 1,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "UST Litigation",
      "mentions": 1,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "UST",
      "mentions": 2,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    },
    {
      "competitor": "fault and/or contributory",
      "mentions": 1,
      "context": "competition in violation of Section 7 of the Clayton Antitrust Act (\u201cClayton Act\u201d).  If the FTC\u2019s challenge is successful, the FTC may order a broad range of remedies, including a requirement of FTC approval of future agreements related to the development, manufacture, distribution or sale of e-vapor products and prohibition against any officer or director of either Altria or JUUL serving on the other party\u2019s board of directors or attending meetings of the other party\u2019s board of directors and no"
    }
  ]
}